Endoron Medical
Catheter-based Endovascular Suturing Device for Abdominal Aortic Aneurysms
Company Overview
Snapshot
Founded in July 2019 by Ronit Harpaz, Dr. Ron Karmeli, and Eyal Teichman, Endoron Medical operates with 11–50 employees. The company has raised $15M across two funding rounds from two investors, with Sofinnova Partners participating in both rounds. In July 2024, Endoron Medical secured Series A funding, led by.
Business overview
Endoron Medical develops medical devices for treating abdominal aortic aneurysms, focusing on improving endovascular aneurysm repair (EVAR) outcomes. Its core product, Aortoseal, is a catheter-based endovascular suturing device designed to provide long-lasting sealing and fixation for endografts. Aortoseal mimics open surgery's hand-sewn suturing technique, distributing staples around the aorta to create leak and migration-free anastomosis. This technology aims to reduce complications and reinterventions, enabling endograft procedures across a broader range of anatomies. The company primarily serves the healthcare industry, specifically hospitals and surgeons, within the medical devices and medical treatment & therapeutics sectors.
Strategic signal
Endoron Medical's successful Series A funding round in July 2024, with continued investment from Sofinnova Partners, signals strong investor confidence in its Aortoseal technology. This capital infusion is crucial for advancing the company's clinical trials and commercialization efforts, indicating a positive trajectory for its innovative solution in the cardiovascular medical device market.
Log in to access full profile ›Company Intelligence Q&A
- What is Endoron Medical's primary product?
- Endoron Medical's primary product is Aortoseal, a catheter-based endovascular suturing device designed for abdominal aortic aneurysm repair, aiming to provide long-lasting sealing and fixation for endografts.
- When was Endoron Medical founded and by whom?
- Endoron Medical was founded in July 2019 by Ronit Harpaz, Dr. Ron Karmeli, and Eyal Teichman.
- Which investors participated in Endoron Medical's Series A funding round?
- In July 2024, Endoron Medical secured Series A funding led by.
- What was a significant early investment in Endoron Medical?
- In December 2021, Sofinnova Partners made an investment in Endoron Medical, as announced from its Medtech Acceleration Fund.
- What is the total capital raised by Endoron Medical?
- Endoron Medical has raised a total of $15M across two funding rounds.